Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists

A technology of quinoxaline and amino, which is applied in the fields of compounds of Group 5/15 elements of the periodic table, metabolic diseases, drug combinations, etc., and can solve problems such as no disclosure or prompting

Inactive Publication Date: 2003-10-29
WARNER-LAMBERT CO
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The application does not disclose or suggest compounds having the amino groups of the present invention as substituents, or the necessary methods for their preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] The substituted quinoxaline-2,3-diones of the present invention are those represented by formula I or pharmaceutically acceptable salts thereof: Wherein R is an amino acid derivative;

[0034] n is an integer of 1-4;

[0035] R 1 is hydrogen, alkyl, aralkyl, carboxyalkyl, phosphoroalkyl, or phosphonoalkyl;

[0036] R 2 is hydrogen, hydroxyl, or amino;

[0037] R 3 and R 4 each independently hydrogen, alkyl, cycloalkyl, alkenyl, halogen, haloalkyl, nitro, cyano, SO 2 CF 3 , C(O)R 6 , where R 6 for hydroxyl, alkoxy, Alkyl, haloalkyl, aryl, aralkyl, CH 2 SO 2 R 6 , (CH 2 ) m CO 2 R 9 , where R 9 is hydrogen, alkyl, aralkyl or cycloalkyl, (CH 2 ) m CONR 7 R 8 , (CH 2 ) m SO 2 NR 7 R 8 , or NHCOR 6 , where m is an integer of 0-4, R 7 and R 8 each independently hydrogen, alkyl, cycloalkyl, haloalkyl, or aralkyl;

[0038] R 5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, halogen, haloalkyl, aryl, heteroaralkyl, aralkyl, heteroaryl, nitro, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention proposes a series of novel substituted quinoxaline 2,3-diones useful as neuroprotective agents. Also proposed are new intermediates, preparation methods and pharmaceutical compositions containing the compound. The compound is a glutamate antagonist and can be used in the treatment of stroke, cerebral ischemia, or cerebral infarction caused by thromboembolic or hemorrhagic stroke, cerebral vasospasm, hypoglycemia, cardiac arrest, status epilepticus, and peripartum asphyxia , hypoxia, Alzheimer's disease, Parkinson's disease and Huntington's disease.

Description

Background of the invention [0001] The present invention relates to novel glutamate receptor antagonists, which are novel compounds of the 5,6,7,8-substituted quinoxaline 2,3-dione type. The a or b position of the fused ring system is replaced by an amino acid derivative. The compound is an excitatory amino acid receptor antagonist acting on glutamate receptors, including N-methyl-D-aspartate (NMDA) receptors and non-NMDA receptors such as α-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid (AMPA) receptor and kainate receptor or either. The present invention also relates to the use of these quinoxaline-2,3-diones as neuroprotective agents for the treatment of conditions caused by various phenomena such as thromboembolic or hemorrhagic stroke, cerebral vasospasm, hypoglycemia, cardiac arrest, status epilepticus, Cerebral ischemia or cerebral infarction caused by peripartum asphyxia, hypoxia (such as due to drowning), lung surgery and brain injury, etc., can also be used in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D241/44C07F9/6509C07C229/18A61K31/495A61P3/08A61P9/00A61P9/06A61P25/00A61P25/04A61P25/08A61P25/18A61P25/20A61P25/28C07C229/14C07C229/20
CPCC07C229/14C07D241/44C07F9/650994A61P25/00A61P25/04A61P25/08A61P25/18A61P25/20A61P25/28A61P3/08A61P9/00A61P9/06
Inventor S·尼卡姆
Owner WARNER-LAMBERT CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap